1. Anonymous. (1993). Update: multistate outbreak of Escherichia coli O157:H7 infections from hamburgers–western United States, 1992-1993. MMWR. Morbidity and Mortality Weekly Report, 42(14), 258–263.
2. Aowicki, D., & Huczynski, A. (2013). Structure and antimicrobial properties of monensin A and its derivatives: summary of the achievements. BioMed Research International, 2013, 742149.
3. Asahara, T., Shimizu, K., Nomoto, K., Hamabata, T., Ozawa, A., & Takeda, Y. (2004). Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infection and Immunity, 72(4), 2240–2247.
4. Barnett, F. D. (2013). Modulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract. Virulence, 4(4), 315–323.
5. Bertin, Y., Deval, C., de la Foye, A., Masson, L., Gannon, V., Harel, J., et al. (2014). The gluconeogenesis pathway is involved in maintenance of enterohaemorrhagic Escherichia coli O157:H7 in bovine intestinal content. PloS One, 9(6), e98367.